Atlas Trials

Study to Assess the Relative Bioavailability of Pacritinib Following Oral Administration as Capsule and Solution Formulations in Healthy Subjects

Clinical trial NCT02808455 · COMPLETED

Trial details

NCT number
NCT02808455
Sponsor
CTI BioPharma
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy Subjects
Start date
2015-01-01
Primary completion
2015-03-01
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.